Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eckstein

Showing results (31-40 of 262) with videos related to

Pageof 27
Sort By:
Urologie (Heidelberg, Germany)|September 1, 2023
[Antibody-drug conjugates directed against NECTIN-4 as a new treatment option for patients with metastatic urothelial carcinoma]Niklas Klümper, Markus Eckstein, Frank Kunath, et al.
Aktuelle Urologie|October 23, 2025
[Pathological Risk Stratification of Non-Muscle-Invasive and Muscle-Invasive Urothelial Carcinoma for Optimal Therapeutic Decision-Making]Fabienne Lange, Nadine Therese Gaisa, Christian Bolenz, et al.
Annals of the Rheumatic Diseases|January 15, 2026
Reply to Correspondence on: 'Effects of different B-cell-depleting strategies on the lymphatic tissue'Carlo Tur, Markus Eckstein, Simon Rauber, et al.
Current Opinion in Urology|November 3, 2025
Nectin-4 in bladder cancer: biology and predictive biomarker potentialNavid Roessler, Marcin Miszczyk, Walter Berger, et al.
European Journal of Immunology|May 5, 2026
Spatial Multiomics Reveal Insights Into ADC EfficacyOsman Goni, Niklas Klümper, Maria Del Mar Muñiz Moreno, et al.
Rheumatology (Oxford, England)|June 26, 2026
Successful use of upadacitinib in refractory bilateral rheumatoid pleural effusionGiulia Corte, Laura Bucci, Sara Bayat, et al.
Urologia Internationalis|January 11, 2023
Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical TrialsChristian Bolenz, Frank Kunath, Friedemann Zengerling, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2024
The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progressionJonas Saal, Markus Eckstein, Manuel Ritter, et al.
Future Oncology (London, England)|June 20, 2019
Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: where we stand and where we goThomas Gevaert, Alessia Cimadamore, Markus Eckstein, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 8, 2024
Diagnosis of malignancy in oropharyngeal confocal laser endomicroscopy using GPT 4.0 with visionMatti Sievert, Marc Aubreville, Sarina Katrin Mueller, et al.
Pageof 27

Showing results (31-40 of 262) with videos related to

Sort By:
Pageof 27
Urologie (Heidelberg, Germany)|September 1, 2023
[Antibody-drug conjugates directed against NECTIN-4 as a new treatment option for patients with metastatic urothelial carcinoma]Niklas Klümper, Markus Eckstein, Frank Kunath, et al.
Aktuelle Urologie|October 23, 2025
[Pathological Risk Stratification of Non-Muscle-Invasive and Muscle-Invasive Urothelial Carcinoma for Optimal Therapeutic Decision-Making]Fabienne Lange, Nadine Therese Gaisa, Christian Bolenz, et al.
Annals of the Rheumatic Diseases|January 15, 2026
Reply to Correspondence on: 'Effects of different B-cell-depleting strategies on the lymphatic tissue'Carlo Tur, Markus Eckstein, Simon Rauber, et al.
Current Opinion in Urology|November 3, 2025
Nectin-4 in bladder cancer: biology and predictive biomarker potentialNavid Roessler, Marcin Miszczyk, Walter Berger, et al.
European Journal of Immunology|May 5, 2026
Spatial Multiomics Reveal Insights Into ADC EfficacyOsman Goni, Niklas Klümper, Maria Del Mar Muñiz Moreno, et al.
Rheumatology (Oxford, England)|June 26, 2026
Successful use of upadacitinib in refractory bilateral rheumatoid pleural effusionGiulia Corte, Laura Bucci, Sara Bayat, et al.
Urologia Internationalis|January 11, 2023
Increasing Biomarker Guidance in the Treatment of Urothelial Carcinoma: Systematic Review of International Clinical TrialsChristian Bolenz, Frank Kunath, Friedemann Zengerling, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2024
The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progressionJonas Saal, Markus Eckstein, Manuel Ritter, et al.
Future Oncology (London, England)|June 20, 2019
Predictive biomarkers for immunotherapy in the treatment of advanced urothelial carcinoma: where we stand and where we goThomas Gevaert, Alessia Cimadamore, Markus Eckstein, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|February 8, 2024
Diagnosis of malignancy in oropharyngeal confocal laser endomicroscopy using GPT 4.0 with visionMatti Sievert, Marc Aubreville, Sarina Katrin Mueller, et al.
Pageof 27